Tenax Therapeutics (TENX) Tops Q1 EPS by 3c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. SPY
9. XYZ
10. FISV

Go back to Tenax Therapeutics (TENX) Tops Q1 EPS by 3c

Tenax Therapeutics Announces First Quarter Fiscal Year 2016 Financial Results

September 14, 2015 6:00 AM EDT

Continued progress in ongoing Phase 3 LEVO-CTS trial in LCOS and LeoPARDS trial in septic shock James Mitchum nominated to Board of Directors Conference call today at 8:30 a.m. ET

MORRISVILLE, N.C.--(BUSINESS WIRE)-- Tenax Therapeutics, Inc. (NASDAQ: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products for the critical care market, today announced financial results for the first quarter fiscal year 2016 ended July 31, 2015, and provided a corporate update.

... More